{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "32975237", "DateCompleted": {"Year": "2021", "Month": "07", "Day": "07"}, "DateRevised": {"Year": "2021", "Month": "07", "Day": "07"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["110"], "Journal": {"ISSN": "0973-7138", "JournalIssue": {"Volume": "45", "Issue": "1", "PubDate": {"Year": "2020"}}, "Title": "Journal of biosciences", "ISOAbbreviation": "J Biosci"}, "ArticleTitle": "<i>Helicobacter pylori</i>: Perturbation and restoration of gut microbiome.", "Abstract": {"AbstractText": ["Alternate remedies with natural products provides unlimited opportunities for new drug development. These can be either as pure compounds or as standardized set of compounds. The phytochemicals and secondary metabolites are in great demand for screening bioactive compounds and plays an important role towards drug development. Natural products have many advantages over to synthetic chemical drugs. <i>Helicobacter pylori</i> (H. pylori) a Gram-negative bacteria has been classified as Class I carcinogen by World Health Organization in 1994. Current treatment regimens for <i>H. pylori</i> is 'triple therapy' administrated for two weeks which includes a combination of two antibiotics like Amoxicillin and Clarithromycin and a proton pump inhibitor (PPI) like Lansoprazole, and for 'quadruple therapy' in addition to antibiotics and a PPI, Bismuth is used. Antibiotic resistance can be named as the main factor for failure of treatment of <i>H. pylori</i> infection. The need of the hour is to develop a herbal remedy that could combat the growth of <i>H. pylori</i>. Probiotics can also be used as 'feasible' tool for <i>H. pylori</i> infection management. Present review is an attempt to briefly discuss about the pathogenicity, genetic predisposition, perturbation of gut microbiota due to antibiotic treatment and restoration of healthy gut microbiota with phytochemicals and probiotics."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Amity Institute of Biotechnology, Amity University, Noida, India."}], "LastName": "Saxena", "ForeName": "Ankita", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Mukhopadhyay", "ForeName": "Asish Kumar", "Initials": "AK"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Nandi", "ForeName": "Shoma Paul", "Initials": "SP"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "India", "MedlineTA": "J Biosci", "NlmUniqueID": "8100809", "ISSNLinking": "0250-5991"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Bacterial Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Biological Products"}, {"RegistryNumber": "0", "NameOfSubstance": "Phytochemicals"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0K5C5T2QPG", "NameOfSubstance": "Lansoprazole"}, {"RegistryNumber": "804826J2HU", "NameOfSubstance": "Amoxicillin"}, {"RegistryNumber": "H1250JIK0A", "NameOfSubstance": "Clarithromycin"}, {"RegistryNumber": "U015TT5I8H", "NameOfSubstance": "Bismuth"}], "MeshHeadingList": [{"QualifierName": ["adverse effects"], "DescriptorName": "Amoxicillin"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Anti-Bacterial Agents"}, {"QualifierName": ["chemistry", "isolation & purification", "therapeutic use"], "DescriptorName": "Biological Products"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Bismuth"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Clarithromycin"}, {"QualifierName": [], "DescriptorName": "Drug Therapy, Combination"}, {"QualifierName": ["chemically induced", "drug therapy", "microbiology", "pathology"], "DescriptorName": "Dysbiosis"}, {"QualifierName": ["drug effects", "physiology"], "DescriptorName": "Gastrointestinal Microbiome"}, {"QualifierName": ["drug therapy", "microbiology", "pathology"], "DescriptorName": "Helicobacter Infections"}, {"QualifierName": ["drug effects", "growth & development", "pathogenicity"], "DescriptorName": "Helicobacter pylori"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Lansoprazole"}, {"QualifierName": ["chemistry", "isolation & purification", "therapeutic use"], "DescriptorName": "Phytochemicals"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Probiotics"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Ahmad K, Farahmand F, Najafi M, Shoaran M. Probiotics for the treatment of Pediatric Helicobacter pylori infection: A randomized double blind clinical trial. Iranial J. Pediat. 2013;23:79\u201384.", "ArticleIdList": ["PMC3574996", "23446685"]}, {"Citation": "Amieva MR, El\u2013Omar EM. Host-Bacterial Interactions in\u00a0Helicobacter pylori\u00a0Infection. Gastroenterology. 2008;134:306\u2013323.", "ArticleIdList": ["18166359"]}, {"Citation": "Appelmelk BJ, Smit IS, Negrini R, Moran AP, Aspinall GO, Forte JG, De-Vries T, Quan H, et al. Potential role of molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens in autoimmunity. Infect. Immun. 1996;64:2031\u20132040.", "ArticleIdList": ["PMC174033", "8675304"]}, {"Citation": "Appelmelk BJ, Vandenbroucke-Grauls CMJE. H. pylori and Lewis antigens. Gut. 2000;47:10\u201311.", "ArticleIdList": ["PMC1727950", "10861253"]}, {"Citation": "Bai Y, Li LR, Wang JD, Chen Y, Jin JF, Zhang ZS, Zhou DY, Zhang YL. Expression of Helicobacter pylori Hsp 60 protein and its immunogenicity. World J. Gastroenterol. 2003;9:2711\u20132714.", "ArticleIdList": ["PMC4612038", "14669319"]}, {"Citation": "Backert S, Selbach M. Role of type IV section in Helicobacter pylori pathogenesis. Cellular Microbiol. 2008;10:1573\u20131581.", "ArticleIdList": ["18410539"]}, {"Citation": "Balch PA and Balch JF 2000 Prescription for Nutritional Healing (Prescription for Nutritional Healing: A Practical A-To-Z Reference to Drug-Free Remedies). 3rd Edition (Avery Publisher)"}, {"Citation": "Bhatia SJ, Kochar N, Abraham P, Nair NG, Mehta AP. Lactobacillus acidophilus inhibits growth of Campylobacter pylori in vitro. J. Clin. Microbiol. 1989;27:2328\u20132330.", "ArticleIdList": ["PMC267018", "2511224"]}, {"Citation": "Bhatt AP, Redinbo MR, Bultman SJ. The role of the microbiome in cancer development and therapy. CA Cancer J. Clin. 2017;67:326\u2013344.", "ArticleIdList": ["PMC5530583", "28481406"]}, {"Citation": "Bellack NR, Koehoorn MW, Macnab YC, Morshed MG. A conceptual model of water\u2019s role as a reservoir in Helicobacter pylori transmission: A review of the evidence. Epidemiol. Infect. 2006;134:439\u2013449.", "ArticleIdList": ["PMC2870436", "16512966"]}, {"Citation": "Bonnet M, Buc E, Sauvanet P, Darcha C, Dubois D, Pereira B, D\u00e9chelotte P, Bonnet R, et al. Colonization of the Human Gut by\u00a0E. coli\u00a0and Colorectal Cancer Risk. Clin. Cancer Res. 2014;20:859\u2013867.", "ArticleIdList": ["24334760"]}, {"Citation": "Bornschein J, Malfertheiner P. Helicobacter pylori and gastric cancer. Dig. Dis. 2014;32:249\u2013264.", "ArticleIdList": ["24732191"]}, {"Citation": "Brown LM. Helicobacter pylori: epidemiology and routes of transmission. Epidemiol. Rev. 2000;22:283\u2013297.", "ArticleIdList": ["11218379"]}, {"Citation": "Buckley M, Lacey S, Doolan A, Goodbody E, Seamans K. The effect of\u00a0Lactobacillus reuteri\u00a0supplementation in\u00a0Helicobacter pylori\u00a0infection: a placebo-controlled, single-blind study. BMCNutrition. 2018 doi: 10.1186/s40795-018-0257-4.", "ArticleIdList": ["10.1186/s40795-018-0257-4", "PMC7050722", "32153909"]}, {"Citation": "Burne RA, Chen YM. Bacterial ureases in inectious diseases. Microbes Infect. 2000;2:533\u2013542.", "ArticleIdList": ["10865198"]}, {"Citation": "Buti L, Spooner E, Van der Veen AG, Rappuoli R, Covacci A, Ploegh HL. Helicobacter pylori cytotoxin-associated gene A (cag A) subverts the apoptosis-estimating protein of p 53 (ASPP2) tumor suppressor pathway of the host. Proc. Natl. Acad. Sci. USA. 2011;108:9238\u20139243.", "ArticleIdList": ["PMC3107298", "21562218"]}, {"Citation": "Bytzer P, Dahlerup JF, Eriksen JR, Jarbol D, Rosenstock S, Wildt S. Diagnosis and treatment of Helicobacter pylori infection. Dan. Med. Bull. 2011;58:C4271.", "ArticleIdList": ["21466771"]}, {"Citation": "Candela M, Turroni S, Biagi E, Carbonero F, Rampelli S, Fiorentini C, Brigidi P. Inflammation and colorectal cancer, when microbiota-host mutualism breaks. World J. Gastroenterol. 2014;20:908\u2013922.", "ArticleIdList": ["PMC3921544", "24574765"]}, {"Citation": "Ca\u00f1izares P, Gracia I, G\u00f3mez LA, Argila CM, Boixeda D, Garc\u00eda A, Rafael L. Allyl-thiosulfinates, the bacteriostatic compounds of garlic against Helicobacter pylori. Biotechnol. Prog. 2004;20:397\u2013401.", "ArticleIdList": ["14763870"]}, {"Citation": "Castellarin M, Warren RL, Freeman JD, Dreolini L, Krzywinski M, Strauss J, Barnes R, Watson P, et al. Fusobacterium nucleatum\u00a0infection is prevalent in human colorectal carcinoma. Genome Res. 2012;22:299\u2013306.", "ArticleIdList": ["PMC3266037", "22009989"]}, {"Citation": "Cellini L, Campli ED, Masulli M, Bartolomeo SD, Allocati N. Inhibition of\u00a0Helicobacter pylori\u00a0by garlic extract (Allium sativum) FEMSImmunol. Microbiol. 1996;13:273\u2013277.", "ArticleIdList": ["8739190"]}, {"Citation": "Cellini L, Bartolomeo SD, Campli ED, Genovese S, Locatelli M, Giulio MD. In vitro activity of Aloe vera inner gel against Helicobacter pylori strains. Lett. in Appl. Microbiol. 2014;59:43\u201348.", "ArticleIdList": ["24597562"]}, {"Citation": "Chatterjee A, Chatterjee S, Bandyopadhyay SK. H. pylori-induces gastric ulcer: Pathophysiology and Herbal remedy. Int. J. Biol. Med. Res. 2012;3:1461\u20131465."}, {"Citation": "Chattopadhyay S, Datta S, Chowdhury A, Mukhopadhyay AK, Rajendran K, Bhattacharya SK, Douglass EB, Nair BG. Virulence genes in Helicobacter pylori strains from West Bengal residents with overt H. pylori-associated disease and healthy volunteers. J. Clin. Microbiol. 2002;40:2622\u20132625.", "ArticleIdList": ["PMC120544", "12089290"]}, {"Citation": "Chung JG, Chen GW, Wu LT, Chang HL, Lin JG, Yeh CC, Wang TF. Effects of garlic compounds diallyl sulfide and diallyl disulfide on arylamine N-acetyltransferase activity in strains of Helicobacter pylori from peptic ulcer patients. Am. J. Chin. Med. 1998;26:353\u2013364.", "ArticleIdList": ["9862023"]}, {"Citation": "Coggins JR, Abell C, Evans LB, Frederickson M, Robinson DA, Roszak AW, Lapthorn AP. Experiences with the shikimate-pathway enzymes as targets for rational drug design. Biochem. Soc. Trans. 2003;31:548\u2013552.", "ArticleIdList": ["12773154"]}, {"Citation": "Compare D, Nardone G. Contribution of Gut Microbiota to Colonic and Extracolonic Cancer Development. Dig. Dis. 2011;29:554\u2013561.", "ArticleIdList": ["22179211"]}, {"Citation": "Cover TL, Blaser MJ. Purification and characterization of the vacuolating toxin from Helicobacter pylori. J. Bio. Chem. 1992;267:10570\u201310575.", "ArticleIdList": ["1587837"]}, {"Citation": "Crew KD, Neugut AI. Epidemiology of gastric cancer. World J. Gastroenterol. 2006;12:354\u2013362. doi: 10.3748/wjg.v12.i3.354.", "ArticleIdList": ["10.3748/wjg.v12.i3.354", "PMC4066052", "16489633"]}, {"Citation": "Czinn SJ, Blanchard T. Vaccinating against Helicobacter pylori infection. Nat. Rev. Gastroenterol. Hepatol. 2011;8:133\u2013140.", "ArticleIdList": ["21304478"]}, {"Citation": "Darini E 2004 Gastric colonization by Helicobacter pylori associated with gene A cytotoxin (cagA): relationship with cell proliferation and apoptosis. PhD thesis, Universidade de S\u00e3o Paulo"}, {"Citation": "De R, Kundu P, Swarnakar S, Ramamurthy T, Chowdhury A, Nair GB, Mukhopadhyay AK. Antimicrobial activity of curcumin against Indian Helicobacter pylori and also during mice infection. J. Antimicrob. Agents and Chemothe. 2009;53:1592\u20131597.", "ArticleIdList": ["PMC2663130", "19204190"]}, {"Citation": "Dunne C, Murphy L, Flynn S, O\u2019Mahony L, O\u2019Halloran S, Feeney M, Morrissey D, Thornton G, et al. Probiotics: from myth to reality. Demonstration of functionality in animal models of disease and in human clinical trials. Antonie Van Leeuwenhoek. 1999;76:279\u2013292.", "ArticleIdList": ["10532384"]}, {"Citation": "Egan BJ, Katicic M, Connor HJO, Morain CAO. Treatment of Helicobacter pylori. Helicobacter. 2007;12:31\u201337.", "ArticleIdList": ["17727458"]}, {"Citation": "Ernst PB, Gold BD. The Disease Spectrum of\u00a0Helicobacter Pylori: The Immunopathogenesis of Gastroduodenal Ulcer and Gastric Cancer. Ann. Rev. Micrbiol. 2000;54:615\u2013640.", "ArticleIdList": ["11018139"]}, {"Citation": "Evans DJ, Jr, Evans DG, Engstrand L, Graham DY. Urease-associated heat shock protein of Helicobacter pylori. Infect. Immun. 1992;60:2125\u20132127.", "ArticleIdList": ["PMC257126", "1348725"]}, {"Citation": "Fiorentino M, Ding H, Blanchard TG, Czinn SJ, Sztein MB, Fasano A. Helicobacter pylori-induced disruption of monolayer permeability and proinflammatory cytokine secretion in polarized human gastric epithelial cells. Infect. Immun. 2013;81:876\u2013883.", "ArticleIdList": ["PMC3584868", "23297384"]}, {"Citation": "Fuller R 1992 History and development of probiotics; in Probiotics (Springer, Dordrecht) pp 1\u20138"}, {"Citation": "Gevers D, Knight R, Petrosino JF, Huang K, McGuire AL, Birren BW, Nelson KE, White O, et al. The Human Microbiome Project: A community resource for the healthy human microbiome. PLoSBiology. 2012 doi: 10.1371/journal.pbio.1001377.", "ArticleIdList": ["10.1371/journal.pbio.1001377", "PMC3419203", "22904687"]}, {"Citation": "Gilani AH, Rahman AU. Trends in ethnopharmocology. J. Ethnopharmacol. 2005;100:43\u201349.", "ArticleIdList": ["16127805"]}, {"Citation": "Gill HS, Guarner F. Probiotics and human health: a clinical perspective. Postgraduate Med. J. 2004;80:516\u2013526.", "ArticleIdList": ["PMC1743098", "15356352"]}, {"Citation": "Graham DY. Helicobacter pylori: Its epidemiology and its role in duodenal ulcer disease. J. Gastroenterol. Hepatol. 1991;6:105\u2013113.", "ArticleIdList": ["1912414"]}, {"Citation": "Graham DY, Malaty HM, Go MF. Are there susceptible host to Helicobacter pylori infection? Scand. J. Gastroenterol. 1994;29:6\u201310.", "ArticleIdList": ["7863244"]}, {"Citation": "G\u00fcrb\u00fcz AK, K\u00fc\u00e7\u00fckkardali Y, Yazgan Y, Ozel M, Polat T. Does eradication of Helicobacter pylori infection reduce hypergastrinema during long term therapy with proton pump inhibitors? Turk. J. Gastroenterol. 2002;13:159\u2013163.", "ArticleIdList": ["16378298"]}, {"Citation": "Herrmann KM, Weaver LM. The shikimate pathway. Annu. Rev. Plant Physiol. Plant Mol. Biol. 1999;50:473\u2013503.", "ArticleIdList": ["15012217"]}, {"Citation": "Holz C, Busjahn A, Mehling H, Arya S, Boettner M, Habibi H, Lang C. Significant reduction in Helicobacter pylori load in humans with non-viable Lactobacillus reuteri DSM17648: A pilot study. Probiotics Antimicrob. Proteins. 2015;7:91\u2013100.", "ArticleIdList": ["PMC4415890", "25481036"]}, {"Citation": "Homan M, Orel R. Are probiotics useful in Helicobacter pylori eradication? World J. Gastroenterol. 2015;21:10644\u201310653.", "ArticleIdList": ["PMC4588086", "26457024"]}, {"Citation": "Houimel M, Corthesy-Theulaz I, Fisch I, Wong C, Corthesy B, Mach J, Finnern R. Selection of human single chain Fv antibody fragments binding and inhibiting Helicobacter pylori urease. Tumour Biol. 2001;22:36\u201344.", "ArticleIdList": ["11054025"]}, {"Citation": "Ilver D, Arnqvist A, Ogren J, Frick IM, Kersulyte D, Incecik ET, Berg DE, Covacci A, et al. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science. 1998;279:373\u2013377.", "ArticleIdList": ["9430586"]}, {"Citation": "Joo M. Rare gastric lesions associated with\u00a0Helicobacter pylori\u00a0infection: A histopathological review. J. Pathol. Transl. Med. 2017;51:251\u2013341.", "ArticleIdList": ["PMC5525039", "28592787"]}, {"Citation": "Kalali B, Luque RM, Javaheri A and Gerhard M 2014 H. pylori\u00a0Virulence factors: influence on immune system and pathology. Mediators Inflamm.10.1155/2014/426309", "ArticleIdList": ["PMC3918698", "24587595"]}, {"Citation": "Kao CY, Sheu BS, Wu JJ. Helicobacter pylori\u00a0infection: An overview of bacterial virulence factors and pathogenesis. Biomed. J. 2016;39:14\u201323.", "ArticleIdList": ["PMC6138426", "27105595"]}, {"Citation": "Karpinski TM. Role of oral microbiota in cancer development. Microorganisms. 2019 doi: 10.3390/microorganisms7010020.", "ArticleIdList": ["10.3390/microorganisms7010020", "PMC6352272", "30642137"]}, {"Citation": "Khodadad A, Farahmand F, Najafi M, Shoaran M. Probiotics for the treatment of pediatric\u00a0Helicobacter Pylori\u00a0infection: A randomized double blind clinical trial. Iran J. Pediatr. 2013;23:79\u201384.", "ArticleIdList": ["PMC3574996", "23446685"]}, {"Citation": "Kim HM, Lee EH, Hong SB, Shin Y. Effect of Syzygium aromaticum extract on immediate hypersensitivity in rat. J. Ethnopharm. 1998;60:125\u2013131.", "ArticleIdList": ["9582002"]}, {"Citation": "Kim JM, Zheng HM, Lee BY, Lee WK, Lee DH. Anti-Helicobacter pylori properties of gut gard. Prev. Nutr. Food Sci. 2013;18:104\u2013110.", "ArticleIdList": ["PMC3892500", "24471118"]}, {"Citation": "Konturek PC, Konturek SJ, Sito E, Kwiecien N, Obtulowicz W, Bielanski W, Hahn EG. Luminal alpha methyl histamine stimulates gastric secretion in duodenal ulcer patients via releasing gastrin. Eur. J. Pharmacol. 2001;301:181\u2013192.", "ArticleIdList": ["11165229"]}, {"Citation": "Kuipers EJ, Pe\u00f1a AS, Festen HP M, Meuwissen SGM, Uyterlinde AM, Roosendaal R, Pals G and Nelis GF 1995 Long-term sequelae of Helicobacter pylori gastritis. 345. https://doi.org/10.1016/S0140\u20136736(95)91084-0", "ArticleIdList": ["7791437"]}, {"Citation": "Kuol CH, Hsu PI, Kuo FC, Wang SSWW, Hu HM, Liu CJ, Chuah SK, Chen YH, Wul DC, Tseng HH. Comparison of 10\u00a0day bismuth quadruple therapy with high-dose metronidazole or levofloxacin for second-line Helicobacter pylori therapy: a randomized controlled trial. J. Chemother. 2013;68:222\u2013228.", "ArticleIdList": ["22984204"]}, {"Citation": "Kusters JG, Vliet AH, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clin. Microbiol. Rev. 2006;19:449\u2013490.", "ArticleIdList": ["PMC1539101", "16847081"]}, {"Citation": "Kwok T, Zabler D, Urman S, Rohde M, Hartig R, Wessler S, Misselwitz R, Berger J, et al. Helicobacter exploits integrin for type IV secretion and kinase activation. Nature. 2007;449:862\u2013866.", "ArticleIdList": ["17943123"]}, {"Citation": "Lapenna D, Curccurollo F. Hypochlorous acid and its pharmacological antagonism: an update picture. Gen. Pharmacol. 1996;27:1145\u20131147.", "ArticleIdList": ["8981059"]}, {"Citation": "Lee A. The microbiology and epidemiology of\u00a0Helicobacter pylori\u00a0infection. Scand. J. Gastroenterol. 2009;29:2\u20136.", "ArticleIdList": ["8047819"]}, {"Citation": "Lehours P, Vale FF, Bjursell MK, Melefors O, Advani R, Glavas S, Guegueniat J, Gontier E, et al. Genome sequencing reveals a phage in Helicobacter pylori. MBio. 2011 doi: 10.1128/mBio.00239-11.", "ArticleIdList": ["10.1128/mBio.00239-11", "PMC3221604", "22086490"]}, {"Citation": "Lind TS, Veldhuyzen van SV, Zanten P, Unge R, Spiller E, Bayerdorffer CO\u2019Morain, Bardhan KD, Bradette M, Chiba N, Wrangstadh M, Cederberg C and Idstrom JP 1996 Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials the MACHI study. Helicobacter1 138\u2013144", "ArticleIdList": ["9398894"]}, {"Citation": "Lin DM, Koskella B, Lin HC. Phage therapy: An alternative to antibiotics in the age of multi-drug resistance. World J. Gastrointest. Pharmacol. Ther. 2017;8:162\u2013173. doi: 10.4292/wjgpt.v8.i3.162.", "ArticleIdList": ["10.4292/wjgpt.v8.i3.162", "PMC5547374", "28828194"]}, {"Citation": "Lloyd KC, Soll AH. Multiple pathways controlling acid secretion. J. Gastroenterol. 1994;29:77\u201379.", "ArticleIdList": ["7921159"]}, {"Citation": "Lopetuso LR, Napoli M, Rizzatti G, Scaldaferri F, Franceschi F, Gasbarrini A. Considering gut microbiota disturbance in the management of Helicobacter pylori infection. Expert Rev. Gastroenterol. Hepatol. 2018;12:899\u2013906.", "ArticleIdList": ["30040500"]}, {"Citation": "Losurdo G, Cubisino R, Barone M, Principi M, Leandro G, Lerardi E, Leo AD. Probiotic monotherapy and Helicobacter pylori eradication: A systematic review with pooled data analysis. World J. Gastroenterol. 2018;24:139\u2013149.", "ArticleIdList": ["PMC5757118", "29358890"]}, {"Citation": "Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. Diversity, stability and resilience of the human gut microbiota. Nature. 2012;489:220\u2013230.", "ArticleIdList": ["PMC3577372", "22972295"]}, {"Citation": "Lychkova AE, Tsaregorodtseva TM, Serova TI. Cytokine profile during experimental gastric and duodenal ulcers: The serotonin role. Eksp. Klin. Gastro entrol. 2010;2:37\u201339.", "ArticleIdList": ["20496807"]}, {"Citation": "Mader HJ, Szostak MP, Hensel A, Lubitz W, Haslberger AG. Endotoxicity does not limit the use of bacterial ghosts as candidate vaccines. Vaccine. 1997;15:195\u2013202.", "ArticleIdList": ["9066038"]}, {"Citation": "Mahdavi J, Son\u00e9n B, Hurtig M, Olfat FO, Forsberg L, Roche N, \u00c5ngstr\u00f6m J, Larsson T, et al. Helicobacter pylori\u00a0SabA adhesin in persistent infection and chronic inflammation. Science. 2002;297:573\u2013578.", "ArticleIdList": ["PMC2570540", "12142529"]}, {"Citation": "Mahady GB, Matsuura H, Pendland SL. Allixin, a phytoalexin from garlic, inhibits the growth of Helicobacter pylori in vitro. Am. J. Gastroenterol. 2001;96:3454\u20133455.", "ArticleIdList": ["11774979"]}, {"Citation": "O\u2019Mahony R, Al-Khtheeri H, Weerasekera D, Fernando N, Vaira D, Holton J, Basset C. Bactericidal and anti-adhesive properties of culinary and medicinal plants against Helicobacter pylori. World J. Gastroenterol. 2005;11:7499\u20137507.", "ArticleIdList": ["PMC4725184", "16437723"]}, {"Citation": "Malfertheiner P, Venerito M, Schulz C. Helicobacter pylori Infection: New facts in Clinical Management. Curr. Treat. Options Gastroenterol. 2018;16:605\u2013615.", "ArticleIdList": ["30415359"]}, {"Citation": "Malfertheiner P, Megraud F, O\u2019Morain CA, Atherton J, Axon ATR, Bazzoli F, Gensini GF, Gisbert JP, et al. Management of Helicobacter pylori infection\u2014the Maastricht IV/ Florence Consensus Report. Gut. 2012;61:646\u2013664.", "ArticleIdList": ["22491499"]}, {"Citation": "Marshall B. Helicobacter pylori: 20\u00a0years on. Clin. Med. 2002;2:147\u2013152.", "ArticleIdList": ["PMC4952378", "11991099"]}, {"Citation": "Marshall BJ, Armistrong JA, McGechie DB, Glancy RJ. Attempt to fulfill kocks postulates for pyloric Campylobacter. Med. J. Aust. 1985;142:436\u2013439.", "ArticleIdList": ["3982345"]}, {"Citation": "Mitchell HM 2001 Epidemiology of infection; in Helicobacter pylori: Physiology and Genetics (eds) HLT Mobley, GL Mendz and SL Hazell (Washington DC, ASM Press) PMID: 21290723", "ArticleIdList": ["21290711"]}, {"Citation": "Montrose DC, Floch MH. Probiotics used in human studies. Ali. Tract: Clin. Rev. 2005;39:469\u2013484.", "ArticleIdList": ["15942432"]}, {"Citation": "Morris AJ, Ali MR, Nicholson GI, Perez GIP, Blaser MJ. Long-term follow-up of voluntary ingestion of Helicobacter pylori. Ann. Internal Med. 1991;114:662\u2013663.", "ArticleIdList": ["2003713"]}, {"Citation": "Mrda Z, Zivanovic M, Rasic J, Gajin S, Somer L, Trbojevic S, Majoros J, Petrovi\u0107 Z. Therapy of Helicobacter pylori infection using Lactobacillus acidophilus. Med. Pregl. 1998;51:343\u2013345.", "ArticleIdList": ["9769669"]}, {"Citation": "Myllyluoma E, Ahlroos T, Veijola L, Rautelin H, Tynkkynen S, Korpela R. Effects of anti-Helicobacter pylori treatment and probiotic supplementation on intestinal microbiota. Int. J. Antimicrob. Agents. 2007;29:67\u201372.", "ArticleIdList": ["17141481"]}, {"Citation": "Nagahata Y, Kawakita N, Azumi Y, Numata N, Yano M, Saitoh Y. Etiological involvement of helicobacter pylori in \u2018reflux\u2019 gastritis after gastrectomy. Am. J. Gastroenterol. 1996;91:2130\u20132134.", "ArticleIdList": ["8855735"]}, {"Citation": "Nazrul IB, Jaripa MD, Nemai CN, Farhana A. Constituents of the essential oil from leaves and buds of clove (Syzigium caryophyllatum L.\u00a0Alston) Afr. J. Plant. Sci. 2010;4:451\u2013454."}, {"Citation": "Nicholson JK, Holmes E, Kinross J, Burcelin R, Gibson G, Jia W, Pettersson S. Host-gut microbiota metabolic interactions. Science. 2012;336:1262\u20131267.", "ArticleIdList": ["22674330"]}, {"Citation": "Noto JM, Peek RM., Jr The gastric microbiome, its interaction with\u00a0Helicobacter pylori, and its potential role in the progression to stomach cancer. PLoS Pathog. 2017 doi: 10.1371/journal.ppat.1006573.", "ArticleIdList": ["10.1371/journal.ppat.1006573", "PMC5629027", "28982167"]}, {"Citation": "Osato MS, Reddy SG, Graham DY. Osmotic effect of honey on growth and viability of Helicobacter pylori. Dig. Dis. Sci. 1999;44:462\u2013464.", "ArticleIdList": ["10080135"]}, {"Citation": "Pan M, Wan C, Xie Q, Huang R, Tao X, Shah NP, Wei H. Changes in gastric microbiota induced by\u00a0Helicobacter pylori\u00a0infection and preventive effects of\u00a0Lactobacillus plantarum\u00a0ZDY 2013 against such infection. J. Dairy Sci. 2016;99:970\u2013981.", "ArticleIdList": ["26709179"]}, {"Citation": "Parker JS. Brain maker: the power of gut microbes to heal and protect your brain\u2013for life. Yale J. Biol. Med. 2016;89:423."}, {"Citation": "Patel SR, Smith K, Letley DP, Gu Q. Helicobacter pylori down regulates expression of human \u03b2-defensin 1 in the gastric mucosa in a type IV secretion-dependent fashion. Cell Microbiol. 2013;15:2080\u20132092.", "ArticleIdList": ["PMC4028989", "23870035"]}, {"Citation": "Pandey R, Misra V, Misra SP, Dwivedi M, Kumar A, Tiwari BK. Helicobacter pylori and gastric cancer. Asian Pac. J. Cancer Prev. 2010;11:583\u2013588.", "ArticleIdList": ["21039020"]}, {"Citation": "Parsonnet J. Helicobacter pylori and gastric cancer. Gastroenterol. Clin. North Am. 1993;22:89\u2013104.", "ArticleIdList": ["8449573"]}, {"Citation": "Patra R, Chattopadhyay S, De R, Ganguly GM, Chowdhury A, Ramamurthy T, Nair GB, Mukhopadhyay AK. Multiple infection and microdiversity among Helicobacter pylori isolates in a single host in India. PLoS One. 2012;7:e43370.", "ArticleIdList": ["PMC3428359", "22952670"]}, {"Citation": "Pounder RE, Ng D. The prevalence of Helicobacter pylori infection in different countries. Alimentary Pharmacology & Therapeutics. 1995;9:33\u201339.", "ArticleIdList": ["8547526"]}, {"Citation": "Quigley EM. Gut bacteria in health and diseases. Gastroenterol. Hepatol. 2013;9:560\u2013569.", "ArticleIdList": ["PMC3983973", "24729765"]}, {"Citation": "Qureshi N, Li P, Gu Q. Probiotic therapy in Helicobacter pylori infection: a potential strategy against a serious pathogen? Appl. Microbiol. Biotechnol. 2019;103:1573\u20131588.", "ArticleIdList": ["30610283"]}, {"Citation": "Rajkumar N, Shanthi G, Shantha Sheela V, Selvakumar S. Antimicrobial activity of Emblica officinalis and Cayratia pedata against Helicobacter pylori. Int. J. Allied Med. Sci. Clin. Res. 2014;2:453\u2013458."}, {"Citation": "Ranade N, Wankhede SS, Ranpise NS, Mundada MS. Development of bilayer floating tablet of Amoxicillin and\u00a0Aloe vera\u00a0gel powder for treatment of gastric ulcers. AAPS Pharm. Sci. Tech. 2012;13:1518\u20131523.", "ArticleIdList": ["PMC3513446", "23135966"]}, {"Citation": "Ridley RG. Planting new targets for antiparasitic drugs. Nat. Med. 1998;4:894\u2013895.", "ArticleIdList": ["9701236"]}, {"Citation": "Roberts FC, Roberts W, Johnson JJ, Kyle DE, Krell T, Coggins JR, Coombs GH, Milhous W, et al. Evidence for the shikimate pathway in apicomplexan parasites. Nature. 1998;393:801\u2013805.", "ArticleIdList": ["9655396"]}, {"Citation": "Rokita E, Makristathis A, Hirschl AM, Rotter ML. Purification of surface-associated urease from Helicobacter pylori. J. Chromatogr. 2000;737:203\u2013212.", "ArticleIdList": ["10681057"]}, {"Citation": "Rolfe RD. The role of probiotic cultures in the control of gastrointestinal health. J. Nutr. 2000;130:396S\u2013402S.", "ArticleIdList": ["10721914"]}, {"Citation": "Rotimi O, Cairns A, Gray S, Moayyedi P, Dixon MF. Histological identification of\u00a0Helicobacter pylori: comparison of staining methods. J. Clin. Path. 2000;53:756\u2013759.", "ArticleIdList": ["PMC1731087", "11064668"]}, {"Citation": "Salama NR, Otto G, Tompkins L, Falkow S. Vacuolating cytotoxin of Helicobacter pylori plays a role during colonization in a mouse model of infection. Infect. Immun. 2001;69:730\u2013736.", "ArticleIdList": ["PMC97945", "11159961"]}, {"Citation": "Sarkar A, De R, Mukhopadhyay AK. Curcumin as a potential therapeutic candidate for Helicobacter pylori associated diseases. World J. Gastroenterol. 2016;22:2736\u20132748.", "ArticleIdList": ["PMC4777996", "26973412"]}, {"Citation": "Savage DC. Microbial ecology of the gastrointestinal tract. Annu. Rev. Microbiol. 1977;31:107\u2013133.", "ArticleIdList": ["334036"]}, {"Citation": "Schoep TD, Fulurija A, Good F, Lu W, Himbeck RP, Schwan C, Choi SS, Berg DE, et al. Surface Properties of\u00a0Helicobacter pylori\u00a0Urease Complex Are Essential for Persistence. Plos One. 2010 doi: 10.1371/journal.pone.0015042.", "ArticleIdList": ["10.1371/journal.pone.0015042", "PMC2993952", "21124783"]}, {"Citation": "Schwabe RF, Jobin C. The microbiome and cancer. Nat. Rev. Cancer. 2013;13:800\u2013812.", "ArticleIdList": ["PMC3986062", "24132111"]}, {"Citation": "Sears CL, Garrett WS. Microbes, microbiota, and colon Cancer. Cell Host Microbe. 2014;15:317\u2013328.", "ArticleIdList": ["PMC4003880", "24629338"]}, {"Citation": "Sen S, Mansell TJ. Yeasts as probiotics: Mechanisms, outcomes and future potential. Fungal Genet. Biol. 2020 doi: 10.1016/j.fgb.2020.103333.", "ArticleIdList": ["10.1016/j.fgb.2020.103333", "31923554"]}, {"Citation": "Servin AL, Coconier MH. Adhesion of probiotic strains to the intestinal mucosa and interaction with pathogens. Best Pract. Res. Clin. Gastroenterol. 2003;17:741\u2013754.", "ArticleIdList": ["14507585"]}, {"Citation": "Sheh A, Fox JG. The role of gastrointestinal microbiome in Helicobacter pylori pathogenesis. Gut Microbes. 2013;4:505\u2013531.", "ArticleIdList": ["PMC3928162", "23962822"]}, {"Citation": "Shetty V, Lamichhane B, Chua EG, Ballal M, Tay CY. Draft Genome sequences of 42\u00a0Helicobacter pylori\u00a0isolates from rural regions of South India. Genome Announc. 2018 doi: 10.1128/genomeA.01486-17.", "ArticleIdList": ["10.1128/genomeA.01486-17", "PMC5794940", "29437093"]}, {"Citation": "Silveira JA, Filho JES, LE Souza O, Souza LBS, Santana WJ, Coutinho HDM. Virulence factors and epidemiologic traits of Helicobacter pylori. Rev. Med. Ana. Costa. 2005;1:1\u201310."}, {"Citation": "Sivam GP, Lampe JW, Ulness B, Swanzy SR, Potter JD. Helicobacter pylori in vitro susceptibility to garlic (Allium sativum) extract. Nutr. Cancer. 1997;27:118\u2013121.", "ArticleIdList": ["9121937"]}, {"Citation": "Smith SM. Role of Toll-like receptors in Helicobacter pylori infection and immunity. World J. Gastrointest. Pathophysiol. 2014;5:133\u2013146.", "ArticleIdList": ["PMC4133513", "25133016"]}, {"Citation": "Somal N, Coley KE, Molan PC, Hancock BM. Susceptibility of Helicobacter pylori to the antibacterial activity of manuka honey. J. R. Soc. Med. 1994;87:9\u201312.", "ArticleIdList": ["PMC1294271", "8308841"]}, {"Citation": "Song HY, Long Z, Liu DY, Yao XJ, Li Y. What role do probitics play in the eradication of Helicobacter pylori? Current knowledge and ongoing research. Gastroenterol. Res. Pract. 2018 doi: 10.1155/2018/9379480.", "ArticleIdList": ["10.1155/2018/9379480", "PMC6206577", "30410538"]}, {"Citation": "Stefano K, Marco M, Federica G, Laura B, Barbara B, Gioacchino L, Francesco di M, Gian LA. Helicobacter pylori, transmission routes and recurrence of infection: state of the art. Acta Biomed. 2018;89:72\u201376.", "ArticleIdList": ["PMC6502203", "30561421"]}, {"Citation": "Suerbaum S, Josenhans C. Helicobacter pylori\u00a0evolution and phenotypic diversification in a changing host. Nat. Rev. Microbiol. 2007;5:441\u2013452.", "ArticleIdList": ["17505524"]}, {"Citation": "Suvarna VC, Boby VU. Probiotics in human health: A current assessment. Curr. Sci. 2005;88:1744\u20131748."}, {"Citation": "Suzuki H, Seto K, Mori M, Suzuki M, Miura S, Ishii H. Monochloramine induced DNA fragmentation in gastric cell line MKN45. Am. J. Physiol. Renal Physiol. 1998;275:712\u2013716.", "ArticleIdList": ["9756501"]}, {"Citation": "Takeuchi H, Trang VT, Morimoto N, Nishida Y, Matsumura Y, Suigura T. Natural products and food components with anti-Helicobacter pylori activities. World J. Gastroenterol. 2014;20:8971\u20138979.", "ArticleIdList": ["PMC4112882", "25083070"]}, {"Citation": "Talley NJ, Phung N, Kalantar JS. Indigestion: When is it functional? Brit. Med. J. 2001;323:1294\u20131297.", "ArticleIdList": ["PMC1121753", "11731396"]}, {"Citation": "Taylor DE, Sherburne R. Helicobacter pylori expresses a complex surface carbohydrate, Lewis X. Am. Soc. Microbiol. 1995;63:4564\u20134568.", "ArticleIdList": ["PMC173655", "7591106"]}, {"Citation": "Torres ME 2017 Parasite guest relationship: normal human flora. http://www.higiene.edu.uy/cefa/Libro2002/Cap%2013.pdf"}, {"Citation": "Tozun N, Vardareli E. Gut microbiome and gastrointestinal cancer: Les liaisons Dangereuses. J. Clin. Gastroenterol. 2016;50:191\u2013196.", "ArticleIdList": ["27741173"]}, {"Citation": "Turnbaugh PJ, Ley RE, Hamady M, Liggett CMF, Knight R, Gordon JI. The Human Microbiome Project. Nature. 2007;449:804\u2013810.", "ArticleIdList": ["PMC3709439", "17943116"]}, {"Citation": "Uchiyama J, Takeuchi H, Kato S, Takemura-Uchiyama I, Ujihara T, Daibata M, Matsuzaki S. Complete genome sequences of two Helicobacter pylori bacteriophages isolated from Japanese patients. J. Virol. 2012;86:11400\u201311401.", "ArticleIdList": ["PMC3457131", "22997420"]}, {"Citation": "Vale FF, Oleastro M. Overview of the phytomedicine approaches against Helicobacter pylori. World J. Gastroenterol. 2014;20:5594\u20135609.", "ArticleIdList": ["PMC4024768", "24914319"]}, {"Citation": "Vale FF, Alves Matos AP, Carvalho P, Vitor JM. Helicobacter pylori phage screening. Microsc. Microanal. 2008;3:150\u2013151."}, {"Citation": "Velin D, Michetti P. Immunology of Helicobacter pylori infection. Dig. 2006;73:116\u2013123.", "ArticleIdList": ["16788292"]}, {"Citation": "Vitor JMB, Vale FF. Alternative therapies for Helicobacter pylori: probiotics and phytomedicine. FEMS Immunol. Med. Microbiol. 2011;63:153\u2013164.", "ArticleIdList": ["22077218"]}, {"Citation": "Wang YC. Medicinal plant activity on Helicobacter related diseases. World J. Gastroenrol. 2014;20:10368\u201310382.", "ArticleIdList": ["PMC4130844", "25132753"]}, {"Citation": "Warren JR, Marshall BJ. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet. 1983;1:1273\u20131275.", "ArticleIdList": ["6134060"]}, {"Citation": "Warren JR, Marshall BJ. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. The Lancet. 1984;323:1311\u20131315.", "ArticleIdList": ["6145023"]}, {"Citation": "Weeks DL, Sachs G. Sites of pH regulation of the urea channel of Helicobacter pylori. Mol Microbiol. 2001;40:1249\u20131259.", "ArticleIdList": ["11442825"]}, {"Citation": "Wu W, Yang Y, Sung G. Recent insights into antibiotic resistance in Helicobacter pylori eradication. Gastroenterol. Res. Pract. 2012;2012:1\u20139.", "ArticleIdList": ["PMC3398622", "22829809"]}, {"Citation": "Yamaguchi H, Osaki T, Taguchi H, Hanawa T, Yamamoto T, Kamiya S. Relationship between expression of HSP60, urease activity, production of vacuolating toxin, and adherence activity of Helicobacter pylori. J. Gastroenterol. 1998;10:6\u20139.", "ArticleIdList": ["9840008"]}, {"Citation": "Yamamura K, Baba Y, Nakagawa S, Mima K, Miyake K, Nakamura K, Sawayama H, Kinoshita K, et al. Human microbiome\u00a0Fusobacterium nucleatum\u00a0in esophageal cancer tissue is associated with prognosis. Clin. Cancer Res. 2016;22:5574\u20135581.", "ArticleIdList": ["27769987"]}, {"Citation": "Yap TWC, Gan HM, Lee YP, Leow AHR, Azmi AN, Francois F, Perez GIP, Loke MF, et al. Helicobacter pylori\u00a0eradication causes perturbation of the human gut microbiome in young adults. PLoS One. 2016;11:e0151893.", "ArticleIdList": ["PMC4798770", "26991500"]}, {"Citation": "Zaidi SF, Sugiyama T. Antibacterial and anti-inflammatory effects of medicinal plants or spices against Helicobacter pylori: A review. Helicobacter Res. 2013;17:430\u2013436."}, {"Citation": "Zaidi SF, Yamada K, Kadowaki M, Usmanghani K, Sugiyama T. Bactericidal activity of medicinal plants, employed for the treatment of gastrointestinal ailments, against Helicobacter pylori. J. Ethnopharmacol. 2009;21:286\u2013291.", "ArticleIdList": ["19041711"]}, {"Citation": "Zaidi SF. Helicobacter pylori\u00a0associated Asian enigma: Does diet deserve distinction? World. J. Gastrointest. Oncol. 2016;8:341\u2013350.", "ArticleIdList": ["PMC4824712", "27096029"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "9", "Day": "25", "Hour": "8", "Minute": "36"}, {"Year": "2020", "Month": "9", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "7", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "9", "Day": "10"}], "PublicationStatus": "ppublish", "ArticleIdList": ["32975237", "PMC7481552", "110", "10.1007/s12038-020-00078-7"]}}], "PubmedBookArticle": []}